The report further revealed that 82 per cent of the participants...
Category:
Facts
Latest
CCPA levies Rs 1 lakh fine on Cloudtail for selling pressure cookers on Amazon in violation of BIS standards
''The company was also directed to pay a penalty of Rs 1,00,000 for...
India has the largest gender wealth gap in APAC:WTW Report
In APAC, the gender wealth gap is the largest in India at 64%. The...
Routine eye scans may give clues to cognitive decline in diabet
These results may open up a relatively easy method for early detection of cognitive decline in this population, providing better ways to understand, diagnose and ultimately treat the decline, said George L. King, MD, Joslin’s Chief Scientific Officer and senior author on a paper about the study in the Journal of Clinical Endocrinology & Metabolism.
WHO recommends two doses of Pfizer COVID-19 vaccine within 21-28 days
“We deliberated and came out with the following recommendation: two doses of this (Pfizer) vaccine within 21-28 days,” Alejandro Cravioto, chairman of WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), told an online news briefing.
More than 85 million people have been reported to be infected by the novel coronavirus globally and around 1.85 million have died, according to a Reuters tally.
Localised herd immunity, young population behind the dip in India’s Covid count?
While there is a glimmer of hope and India’s Covid-19 numbers are on a definite decline for a combination of reasons, a vaccination programme continues to be important, particularly given the presence of a mutant, more transmissible strain, several experts said while cautioning against infection upticks ahead.
Consumers feel higher importance of sanitisation; cloth wash frequency rises amid pandemic: Survey
Commenting on the findings, Whirlpool of India Vice-President (Marketing) K G Singh said, ”People today are more vigilant of their health and hygiene than ever before.” An official spokesperson from Kantar said the survey clearly indicates the stress and worry around sanitisation of clothes.
China doubles down on COVID narrative as WHO investigation looms
Raina MacIntyre, head of the Kirby Institute’s Biosecurity Research Program in Australia, said the investigation needed to draw “a comprehensive global picture of the epidemiological clues”, including any evidence COVID-19 was present outside of China before December 2019.
As end to pandemic mask-wearing nears, South Koreans scramble to arrange cosmetic surgery in the future
“Both surgical and non-surgical inquiries about eyes, eyebrows, nose bridge and foreheads – the only visible parts – certainly increased,” said Park Cheol-woo, a surgeon at WooAhIn Plastic Surgery Clinic, who was in charge of Ryu’s operation.
Study uncovers blood vessel damage, inflammation in COVID-19 patients’ brains
The researchers saw no signs of infection in the brain tissue samples even though they used several methods for detecting genetic material or proteins from SARS-CoV-2.
“So far, our results suggest that the damage we saw may not have been not caused by the SARS-CoV-2 virus directly infecting the brain,” said Dr. Nath. “In the future, we plan to study how COVID-19 harms the brain’s blood vessels and whether that produces some of the short- and long-term symptoms we see in patients.”
Coronavirus vaccines could have potential allergic reactions, assures new studyBoston
The study published in the Journal of Allergy and Clinical Immunology, in response to accounts of potential allergic reactions in some people following COVID-19 vaccination in the United Kingdom, that country’s medical regulatory agency advised that individuals with a history of anaphylaxis to medicine or food should avoid COVID-19 vaccination.
China’s Bottled Water King Dethrones Mukesh Ambani As Asia’s Richest Person
Zhong’s net worth has surged $70.9 billion this year to $77.8 billion, making him the 11th-richest person on the planet, according to the Bloomberg Billionaires Index. It’s one of the fastest accumulations of wealth in history, and all the more remarkable considering that until this year he was little known outside of China.
after an improbable career spanning journalism, mushroom farming and health care, he’s become Asia’s richest person, eclipsing India’s Mukesh Ambani and a group of Chinese tech titans including Jack Ma.
Assessing 2020:Fight against COVID-19 kept health ministry on its toes
At present, six COVID-19 vaccines are undergoing clinical trials in India.
They are: Covaxin, developed by Bharat Biotech in collaboration with ICMR; Oxford vaccine manufactured by SII under licence from AstraZeneca; ZyCOV-D being developed by Cadila Healthcare Ltd in Ahmedabad in collaboration with the Centre”s Department of Biotechnology; Sputnik V vaccine manufactured by Dr Reddy”s Lab, Hyderabad, in collaboration with Russia”s Gamaleya National Centre; one manufactured by Biological E Ltd, Hyderabad, in collaboration with MIT, US and the sixth developed by Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, US.
Besides, there is NVX-CoV2373, which is being developed by SII in collaboration with Novavax and its phase-3 clinical trial is under consideration with the drug regulator.